Canal Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$455K Hold
2,906
0.06% 143
2026
Q1
$444K Hold
2,906
0.06% 136
2025
Q4
$401K Hold
2,906
0.06% 131
2025
Q3
$373K Sell
2,906
-539
-16% -$65.8K 0.06% 137
2025
Q2
$417K Buy
3,445
+215
+7% +$24.2K 0.07% 125
2025
Q1
$360K Hold
3,230
0.06% 126
2024
Q4
$314K Sell
3,230
-2,010
-38% -$214K 0.05% 139
2024
Q3
$603K Buy
5,240
+56
+1% +$6.35K 0.1% 92
2024
Q2
$552K Hold
5,184
0.09% 92
2024
Q1
$501K Hold
5,184
0.08% 94
2023
Q4
$523K Buy
5,184
+280
+6% +$27K 0.1% 99
2023
Q3
$500K Hold
4,904
0.1% 92
2023
Q2
$495K Hold
4,904
0.1% 95
2023
Q1
$451K Hold
4,904
0.1% 98
2022
Q4
$445K Hold
4,904
0.11% 109
2022
Q3
$373K Buy
4,904
+65
+1% +$5.39K 0.11% 103
2022
Q2
$409K Hold
4,839
0.12% 100
2022
Q1
$425K Sell
4,839
-39,906
-89% -$3.46M 0.11% 104
2021
Q4
$3.91M Buy
44,745
+2,006
+5% +$167K 0.94% 31
2021
Q3
$3.5M Sell
42,739
-221
-0.5% -$19.9K 1% 30
2021
Q2
$3.92M Buy
42,960
+3,184
+8% +$284K 1.13% 25
2021
Q1
$3.4M Buy
39,776
+4,276
+12% +$384K 1.16% 28
2020
Q4
$3.35M Buy
35,500
+508
+1% +$44.4K 1.26% 25
2020
Q3
$3.04M Buy
34,992
+505
+1% +$43.7K 1.33% 22
2020
Q2
$3.01M Buy
34,487
+358
+1% +$30.9K 1.47% 20
2020
Q1
$2.81M Buy
34,129
+3,895
+13% +$348K 1.59% 19
2019
Q4
$2.86M Buy
30,234
+1,255
+4% +$113K 1.45% 23
2019
Q3
$2.52M Buy
28,979
+307
+1% +$27.6K 1.51% 24
2019
Q2
$2.62M Sell
28,672
-1,313
-4% -$111K 1.59% 18
2019
Q1
$2.58M Buy
29,985
+325
+1% +$26.1K 1.64% 15
2018
Q4
$2.28M Buy
29,660
+993
+3% +$77.3K 1.55% 16
2018
Q3
$2.21M Buy
28,667
+1,019
+4% +$75.3K 1.26% 20
2018
Q2
$1.87M Buy
27,648
+1,031
+4% +$71.1K 1.04% 26
2018
Q1
$1.93M Sell
26,617
-843
-3% -$64.2K 1.11% 28
2017
Q4
$2.07M Buy
27,460
+3,612
+15% +$273K 1.14% 24
2017
Q3
$1.83M Sell
23,848
-2,145
-8% -$162K 1.08% 30
2017
Q2
$1.94M Buy
25,993
+3,459
+15% +$245K 1.2% 23
2017
Q1
$1.5M Buy
22,534
+13,290
+144% +$886K 1.02% 30
2016
Q4
$603K Buy
9,244
+3,586
+63% +$233K 0.49% 51
2016
Q3
$400K Buy
5,658
+84
+2% +$6.12K 0.37% 51
2016
Q2
$412K Buy
5,574
+267
+5% +$18.4K 0.43% 48
2016
Q1
$344K Buy
+5,307
New +$361K 0.35% 54

Other funds holding NVS

Canal Capital Management's NVS Position: Q2 2026 in Review

Canal Capital Management held its Novartis (NVS) position steady in Q2 2026 at 2,906 shares worth $455K. The position accounts for 0.06% of the portfolio, ranked #143.

Canal Capital Management first reported a position in NVS in Q1 2016 and has held it in 42 quarters since. The position peaked at $3.92M in Q2 2021. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Canal Capital Management held 2,906 shares of Novartis worth $455K as of Q2 2026.
  • Canal Capital Management left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.06% of Canal Capital Management's portfolio in Q2 2026, its #143 holding.
  • Canal Capital Management first reported a position in Novartis in Q1 2016 and has held it in 42 quarters since.
  • Canal Capital Management's Novartis position peaked at $3.92M in Q2 2021.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Canal Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.